CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
-3.38%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$934M
AUM Growth
+$29.8M
(+3.3%)
Cap. Flow
+$61.9M
Cap. Flow
% of AUM
6.63%
Top 10 Holdings %
Top 10 Hldgs %
51.09%
Holding
212
New
29
Increased
119
Reduced
37
Closed
8
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 4.37% |
| 2 | Healthcare | 1.15% |
| 3 | Financials | 1.02% |
| 4 | Communication Services | 0.66% |
| 5 | Consumer Discretionary | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRXH
201
SRX Health Solutions, Inc.
SRXH
$12.7M
| $30.2K | ﹤0.01% |
7,465
+3,068
| +70% | +$12.4K |
|
202
Lloyds Banking Group
LYG
$65B
| $24.3K | ﹤0.01% |
+11,391
| New | +$24.3K |
|
203
ImmunityBio
IBRX
$2.26B
| $17.8K | ﹤0.01% |
+10,555
| New | +$17.8K |
|
|
EFTR
204
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $12K | ﹤0.01% |
800
| – | – |
|
205
Vanguard Short-Term Bond ETF
BSV
$38.4B
| – | – |
-20,760
| Closed | -$1.57M |
|
206
eXp World Holdings
EXPI
$1.72B
| – | – |
-10,568
| Closed | -$214K |
|
207
IQVIA
IQV
$31.3B
| – | – |
-1,150
| Closed | -$258K |
|
208
Cohen & Steers Duration Preferred & Income Fund
LDP
$626M
| – | – |
-10,000
| Closed | -$182K |
|
209
Royal Caribbean
RCL
$97.8B
| – | – |
-2,100
| Closed | -$218K |
|
210
iShares 20+ Year Treasury Bond ETF
TLT
$48.1B
| – | – |
-4,633
| Closed | -$477K |
|
211
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| – | – |
-24,472
| Closed | -$1.85M |
|
|
INFI
212
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
-158,500
| Closed | -$33.4K |
|